|
000
| 02688nam 2200409zi 4500 |
|---|
| 001 | 9.921499 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20231005083350 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 230404t20222023onco o f100 0 eng d |
|---|
| 020 | |a9780660482828|z9780660482842 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aMR4-139/2023E-PDF|zMR4-139/2023F-PDF |
|---|
| 245 | 00|aOperating grant : |bevaluation of harm reduction approaches to address the opioid crisis in the context of COVID-19 - supervised consumption sites evaluation : end-of-grant virtual workshop - what we heard report. |
|---|
| 264 | 1|aOttawa, ON : |bCanadian Institutes of Health Research = Instituts de recherche en santé du Canada, |c2022. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (16 pages) : |bphotographs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Workshop Date: October 28, 2022." |
|---|
| 500 | |a"Location: Virtual Meeting via MS Teams." |
|---|
| 500 | |aIncorrect catalogue number (MR4-139/2023F-PDF) and ISBN (9780660482842) printed in this publication. |
|---|
| 500 | |aIssued also in French under title: Subvention de fonctionnement : évaluation des approches de réduction des méfaits face à la crise des opioïdes dans le contexte de la COVID-19 - évaluation des sites de consommation supervisée - atelier virtuel de fin de subvention - compte rendu. |
|---|
| 520 | |a"On October 28, 2022, the Canadian Institutes of Health Research (CIHR) hosted a virtual end-of-grant knowledge exchange workshop for four one-year supervised consumption sites (SCS) evaluation projects funded through the Operating Grant : Evaluation of Harm Reduction Approaches to Address the Opioid Crisis in the Context of COVID-19 funding opportunity. This report comprises a synthesis of the evidence presented by the four research teams and a summary of knowledge user and audience perspectives shared during a panel reflections and discussion session"--Introduction, page 4. |
|---|
| 650 | 0|aOpioids|xOverdose|xResearch|zCanada|vCongresses. |
|---|
| 650 | 0|aDrug abuse|xSocial aspects|zCanada|vCongresses. |
|---|
| 650 | 0|aCOVID-19 (Disease)|xSocial aspects|zCanada|vCongresses. |
|---|
| 655 | 7|aConference papers and proceedings|2lcgft |
|---|
| 710 | 2 |aCanadian Institutes of Health Research, |eissuing body. |
|---|
| 775 | 08|tSubvention de fonctionnement : |w(CaOODSP)9.921502 |
|---|
| 856 | 40|qPDF|s717 KB|uhttps://publications.gc.ca/collections/collection_2023/irsc-cihr/MR4-139-2023-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://cihr-irsc.gc.ca/e/53469.html |
|---|